Insights Into AN2 Therapeutics Inc (ANTX) Exposure By Institutions

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Most recently, Yahoo Finance reported about the stock as it publicized that AN2 Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business and Scientific Highlights.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Stocks Info

AN2 Therapeutics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of AN2 Therapeutics Inc is $101.22M. A total of 0.52 million shares were traded on the day, compared to an average of 422.84K shares.

In the most recent transaction, Zakrzewski Joseph S sold 100,000 shares of ANTX for 19.11 per share on Jan 18 ’24. After the transaction, the Director now owns 405,880 company shares. In a previous transaction on Jan 16 ’24, Aziz Kabeer sold 100,000 shares at 19.65 per share. ANTX shares that Director owns now total 377,542.

Among the insiders who sold shares, Adjuvant Global Health Technol disposed of 84,093 shares on Jan 16 ’24 at a per-share price of $19.65. This resulted in the 10% Owner holding 1,995,958 shares of ANTX after the transaction. In another insider transaction, Adjuvant Global Health Technol sold 15,907 shares at $19.65 per share on Jan 16 ’24. Company shares held by the 10% Owner now total 377,542.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, ANTX has a high of $22.22 and a low of $2.72.

As of this writing, ANTX has an earnings estimate of -$0.73 per share for the current quarter. EPS was calculated based on a consensus of 4 estimates, with a high estimate of -$0.59 per share and a lower estimate of -$0.79. The company reported an EPS of -$0.65 in the last quarter, which was -3.20% lower than expectations of -$0.63.

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. ANTX’s latest balance sheet shows that the firm has $58.55M in Cash & Short Term Investments as of fiscal 2021. There were $0.00 in debt and $3.40M in liabilities at the time. Its Book Value Per Share was $4.19, while its Total Shareholder’s Equity was $61.91M.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ANTX is Buy with a score of 3.40.

Most Popular

Related Posts